Identification of Antineoplastic Targets with Systems Approaches, Using Resveratrol as an In-Depth Case Study
Nivedita Singh1, Sherry Freiesleben2, Olaf Wolkenhauer2
1CSIR-Indian Institute of Toxicology Research, Lucknow, Uttar Pradesh. India.
Abstract:
The identification and validation of novel drug-target combinations are key steps in the drug discovery processes. Cancer is a complex disease that involves several genetic and environmental factors. High-throughput omics technologies are now widely available, however the integration of multi-omics data to identify viable anticancer drug-target combinations, that allow for a better clinical outcome when considering the efficacy-toxicity spectrum, is challenging. This review article provides an overview of systems approaches which help to integrate a broad spectrum of technologies and data. We focus on network approaches and investigate anticancer mechanism and biological targets of resveratrol using reverse pharmacophore mapping as an in-depth case study. The results of this case study demonstrate the use of systems approaches for a better understanding of the behavior of small molecule inhibitors in receptor binding sites. The presented network analysis approach helps in formulating hypotheses and provides mechanistic insights of resveratrol in neoplastic transformations.
Insights
This review explores systems approaches for integrating multi-omics data to discover novel anticancer drug-target combinations. A case study on resveratrol highlights network analysis for understanding its mechanisms in cancer.
Area of Science:
- Computational biology
- Pharmacology
- Oncology
Background:
- Drug discovery relies on identifying effective drug-target combinations.
- Cancer's complexity necessitates integrating multi-omics data for better treatment strategies.
- Challenges exist in combining diverse data for anticancer drug development, balancing efficacy and toxicity.
Purpose of the Study:
- To review systems approaches for integrating multi-omics data in drug discovery.
- To investigate anticancer mechanisms and targets of resveratrol using network analysis.
- To demonstrate the utility of systems approaches for understanding small molecule-target interactions.
Main Methods:
- Review of systems biology approaches for data integration.
- Network analysis to study biological mechanisms.
- Reverse pharmacophore mapping as a case study for resveratrol.
Main Results:
- Systems approaches facilitate the integration of various data types for drug discovery.
- Network analysis provides mechanistic insights into resveratrol's anticancer effects.
- Reverse pharmacophore mapping aids in understanding small molecule binding to targets.
Conclusions:
- Systems approaches are crucial for advancing anticancer drug discovery.
- Network analysis offers a powerful tool for hypothesis generation and mechanistic understanding.
- Resveratrol's anticancer properties can be further elucidated through these computational methods.
More Related Videos
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Targeted Cancer Therapies
There are several types of targeted therapies against...


